CFTR and cystic fibrosis: Altogether, these data suggest that part of the CF phenotype expressed in humans might depend on the function of myeloid cells and can therefore represent a relevant target for current therapeutic strategies where the anti-inflammatory properties of CFTR modulator combinations, in addition to their ability to stimulate CFTR function, might contribute to improved clinical outcomes.